Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients

Annals of Surgical Treatment and Research

Volumn 88, Issue 2, 2015, Pages 100-105

  Song, Seung Hwan ^a   Kim, Myoung Soo ^a,b   Lee, Jung Jun ^c   Ju, Man Ki ^a,b   Lee, Jae Geun ^a,b   Lee, Juhan ^a,b   Choi, Jin Sub ^a,b   Choi, Gi Hong ^a,b   Kim, Soon Il ^a,b   Joo, Dong Jin ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c CHA University   (South Korea)

Author keywords

Acute rejection; Donor specific antibody; Graft survival; Liver transplantation; Sensitization

Indexed keywords

EID: 84981357261     PISSN: 22886575     EISSN: 22886796     Source Type: Journal    
DOI: 10.4174/astr.2015.88.2.100     Document Type: Article

References (17)

1. Hori T, Uemoto S, Takada Y, Oike F, Ogura Y, Ogawa K, et al. Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation? Surgery 2010;147:840-4.
2. Suehiro T, Shimada M, Kishikawa K, Shimura T, Soejima Y, Yoshizumi T, et al. Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation. Liver Int 2005;25:1182-8.
3. Ratner LE, Hadley GA, Hanto DW, Mohanakumar T. Immunology of renal allograft rejection. Arch Pathol Lab Med 1991;115:283-7.
4. Abu-Elmagd KM, Wu G, Costa G, Lunz J, Martin L, Koritsky DA, et al. Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Am J Transplant 2012;12:3047-60.
5. Pons JA, Revilla-Nuin B, Ramirez P, Baroja-Mazo A, Parrilla P. Development of immune tolerance in liver transplantation. Gastroenterol Hepatol 2011;34:155-69.
6. Taner T, Gandhi MJ, Sanderson SO, Poterucha CR, De Goey SR, Stegall MD, et al. Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant 2012;12:1504-10.
7. Sugawara Y, Makuuchi M, Kaneko J, Kishi Y, Hata S, Kokudo N. Positive T lymphocytotoxic cross-match in living donor liver transplantation. Liver Transpl 2003;9:1062-6.
8. Suh KS, Kim SB, Chang SH, Kim SH, Minn KW, Park MH, et al. Significance of positive cytotoxic cross-match in adult-to-adult living donor liver transplantation using small graft volume. Liver Transpl 2002;8:1109-13.
9. Joo DJ, Ju MK, Huh KH, Kim MS, Choi GH, Choi JS, et al. Does lymphocyte cross-matching predict acute rejection and graft survival in liver transplantation? Transplant Proc 2012;44:418-20.
10. Matinlauri IH, Hockerstedt KA, Isoniemi HM. Equal overall rejection rate in pretransplant flow-cytometric cross-match negative and positive adult recipients in liver transplantation. Clin Transplant 2005;19:626-31.
11. Heeger PS, Dinavahi R. Transplant immunology for non-immunologist. Mt Sinai J Med 2012;79:376-87.
12. Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998;28:638-45.
13. Lan X, Zhang MM, Pu CL, Guo CB, Kang Q, Li YC, et al. Impact of human leukocyte antigen mismatching on outcomes of liver transplantation: a meta-analysis. World J Gastroenterol 2010;16:3457-64.
14. Everly MJ. Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients. Clin Transpl 2011:319-25.
15. O'Leary JG, Klintmalm GB. Impact of donor-specific antibodies on results of liver transplantation. Curr Opin Organ Transplant 2013;18:279-84.
16. O'Leary JG, Kaneku H, Jennings LW, Bañuelos N, Susskind BM, Terasaki PI, et al. Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation. Liver Transpl 2013;19:973-80.
17. Kaneku H, O'Leary JG, Banuelos N, Jennings LW, Susskind BM, Klintmalm GB, et al. De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients. Am J Transplant 2013;13:1541-8.